Cardiovascular Innovations 2024: The Operators Enclave

Cardiovascular Innovations 2024: The Operators Enclave(TM) is a world-class meeting focused on state-of-the-art therapy for peripheral, coronary, and structural heart disease. The conference features:

• Highly interactive expert discussions focused on professional experiences
• An emphasis on the latest innovations in interventional cardiovascular care
• Cased-based presentations by the leading operators in the United States and Europe
• TWO NEW TRACKS for Aortic and Interventional Heart Failure

Included with registration

• 50+ sessions over two and a half days across five specialty tracks
• Pre-conference Fellows Bootcamp: Success with Interventional Fellowship and Beyond (7/17)
• A wide variety of satellite symposia and hands-on workshops
• Multiple networking events
• Exhibit hall with the latest innovations and technology

Cardiovascular Innovations 2024: The Operators Enclave(TM) is designed to meet the needs of cardiologists, surgeons, internists, trainees, investigators, nurses, nurse practitioners, physician assistants and allied health care staff who participate in the care of patients with coronary, peripheral, and structural cardiovascular diseases. The focus of the conference is on innovative health care solutions for these patients.

Cardiovascular disease is the number one cause of death globally, accounting for nearly 17.5 million deaths each year. Cardiovascular disease may strike those in their prime years and, due to population aging, also afflict elderly people who are otherwise living healthy lives. Improvements in cardiovascular therapy have markedly reduced procedural risk, and thereby enabled the treatment of a broad range of patients, more than ever before in the history of medicine. Nonetheless, significant disparities in the delivery of cardiovascular care continue to exist, leading to large unmet clinical needs for many patients worldwide. Innovation in the delivery of cardiovascular care, as well as education of the public at-large, is essential for optimizing the management of these patients.

The Cardiovascular Innovations Foundation is organized and operated exclusively for charitable, scientific, and educational purposes within the meaning of Section 501(c)(3) of the Internal Revenue Code.

The mission of the Foundation is to address unmet needs in cardiovascular care through the study, design, and development of innovative health care solutions and education of health care providers and the larger public.

Subhash Banerjee, MD, FACC, FSCAI

Baylor Heart and Vascular Hospital, Dallas, TX

Emmanouil S. Brilakis, MD, PhD, FACC, FAHA, FSCAI, FESC

Minneapolis Heart Institute at Abbott Northwestern Hospital

Mehdi H. Shishehbor, DO, MPH, PhD, FACC, FAHA, FSCAI

University Hospitals Harrington Heart & Vascular Institute

Paul Sorajja, MD, FACC, FAHA, FSCAI

Minneapolis Heart Institute at Abbott Northwestern Hospital

Host or Publisher Cardiovascular Innovations Foundation